GT Biopharma (GTBP) Shares Issued (2010 - 2026)
GT Biopharma (GTBP) posted quarterly Shares Issued of $597550.0 for Q1 2026, up 454.59% year-over-year from $107746.0 in Q1 2025, and little changed quarter-over-quarter from $597550.0 in Q4 2025.
GT Biopharma (GTBP) Shares Issued (2010 - 2026) Analysis & Trends
GT Biopharma (GTBP) has reported Shares Issued for 15 consecutive years, with $597550.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Shares Issued rose 454.59% year-over-year to $597550.0; the TTM figure through Mar 2026 stood at $597550.0 (up 454.59% YoY), while the FY2025 annual figure was $597550.0, up 379.57% from the prior year.
- Shares Issued held at $597550.0 in Q1 2026 per GTBP's latest filing, from $597550.0 in the prior quarter.
- Across five years, Shares Issued topped out at $597550.0 in Q4 2025 and bottomed at $107746.0 in Q1 2025.
- Historically, Shares Issued has averaged $294263.1 across 4 years, with a median of $126265.0 in 2023.
- Annual changes were most pronounced in 2024 — Shares Issued fell 1.32% — and 2026, when it surged 454.59%.
- GT Biopharma's Shares Issued stood at $126265.0 in 2023, then dropped by 1.32% to $124600.0 in 2024, then surged by 379.57% to $597550.0 in 2025, then changed by 0.0% to $597550.0 in 2026.
- Business Quant data shows GTBP's Shares Issued at $597550.0 in Q1 2026, $597550.0 in Q4 2025, and $396439.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | GT Biopharma | 8.64 Mn | 8.64 Mn | - | 597,550.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 597,550.00 |
| Mar 31, 2026 | 597,550.00 |
| Dec 31, 2025 | 597,550.00 |
| Dec 31, 2025 | 597,550.00 |
| Sep 30, 2025 | 396,439.00 |
| Sep 30, 2025 | 396,439.00 |
| Jun 30, 2025 | 109,692.00 |
| Jun 30, 2025 | 109,692.00 |
| Mar 31, 2025 | 107,746.00 |
| Mar 31, 2025 | 107,746.00 |
| Dec 31, 2024 | 124,600.00 |
| Dec 31, 2024 | 124,600.00 |
| Dec 31, 2023 | 126,265.00 |
| Dec 31, 2023 | 126,265.00 |
| Sep 30, 2020 | 40.00 |
| Sep 30, 2020 | 40.00 |
| Jun 30, 2020 | 40.00 |
| Jun 30, 2020 | 40.00 |
| Mar 31, 2020 | 40.00 |
| Mar 31, 2020 | 40.00 |